KNTE

Kinnate Biopharma Inc. Common Stock

Delisted

KNTE was delisted on the 2nd of April, 2024.

84 hedge funds and large institutions have $472M invested in Kinnate Biopharma Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 27 increasing their positions, 19 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
84
Holders Change
+11
Holders Change %
+15.07%
% of All Funds
1.45%
Holding in Top 10
6
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.1%
New
16
Increased
27
Reduced
19
Closed
5
Calls
$569K
Puts
Net Calls
+$569K
Net Calls Change
-$46K